𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder

✍ Scribed by Abraham Pavlotsky; Abraham Eidelman; Frida Barak; Haim Alon; Dr. Yoav Horn


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
301 KB
Volume
41
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


We treated 47 patients with recurrent transitional cell carcinoma of the bladder with intravesical chemotherapy. Twenty milligrams of mitomycin C per treatment was introduced 7 days after transurethral resection (TUR) or diagnostic cystoscopy, and was repeated at 2-week intervals for five times followed again by cystoscopy. Two more similar courses were administered for a total of 36 weeks. Clinical data revealed no toxicityrelated symptoms. Cystoscopic follow-up showed a gradual decline in the presence of tumor to a complete response rate of 87.1 % at 36 weeks. Thirteen patients who were previously treatment failures with other drugs responded to mitomycin C.


πŸ“œ SIMILAR VOLUMES


Coexisting leiomyosarcoma and transition
✍ Dr. Karl T. K. Chen πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 498 KB πŸ‘ 2 views

A rare case of coexisting sarcoma and carcinoma of the urinary bladder is reported and the literature is reviewed. Because of the differences in the histogenesis and prognosis, such cases should be differentiated from cases of carcinosarcoma of the urinary bladder.

The significance of ureteral obstruction
✍ Dr. Ilan Leibovitch; Jacob Ben-Chaim; Jacob Ramon; Igael Madjar; Izchak S. Engel πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 477 KB πŸ‘ 2 views

## Abstract Ureteral obstruction is a frequent complication of transitional cell carcinoma (TCC), known as a poor prognostic sign and indicative of advanced disease. We investigated retrospectively the medical records of 122 consecutive patients who suffered from invasive TCC of the urinary bladder

Doxorubicin plus mitomycin C regimen in
✍ Valentino Ferraris πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 485 KB πŸ‘ 2 views

Sixty patients with superficial papillary bladder cancer, Stages Ta and T1, received chemoprophylactic treatment to prevent recurrences after the complete resection of the primary lesion. The prophylactic regimen consisted of endovesical instillations alternating doxorubicin and mitomycin C. The fir